Discovering Factors in Metastatic Breast Cancer Patients' Clinical Trial Experiences
Not yet recruiting
- Conditions
- Metastatic Breast Cancer
- Registration Number
- NCT05760183
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Enrollment in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.
This trial will evaluate the safety and efficacy of metastatic breast cancer treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.
It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future metastatic breast cancer studies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Patient is at least 18 years of age
- Patient is able and willing to comply with the treatment/follow-up schedule and requirements
- Patient must provide written informed consent
Exclusion Criteria
- Women who are pregnant, intend to become pregnant, or are lactating
- Inability to perform regular electronic reporting
- Participants who are vulnerable to any intervention
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a metastatic breast cancer clinical study. 3 months Number of metastatic breast cancer study participants who remain in clinical trial until completion. 12 months
- Secondary Outcome Measures
Name Time Method